Digital technologies for the treatment of glaucoma
https://doi.org/10.25700/NJG.2020.04.02
Abstract
The large selection of drugs for reduction of intraocular pressure expands the possibilities of drug treatment of glaucoma. At the same time, it creates certain difficulties for doctors preparing a complex, multicomponent scheme of several names of drugs. The mobile application "GlauHint" was developed for doctors dealing with glaucoma treatment. It provides technical assistance in drawing up the correct drug therapy regimen. The application allows checking the treatment that the patient is receiving and making corrections to it, as well as comprising the right combination of drugs, excluding the coincidence of active substances of the same class.
About the Authors
S. Yu. Kazanova
Central City Hospital
Russian Federation
Russian Federation
M.D., Head of Glaucoma Department
52 Oktyabrya Avenue, Yaroslavl, 150040
Yu. A. Kazanov
Yaroslavl State University
Russian Federation
Russian Federation
Student
14 Sovetskaya st., Yaroslavl, 150003
References
1. Astakhov Yu.S., Nechiporenko P.A. Prostaglandin analogues: past, present, and future. Oftalmologičeskie vedomosti. 2017; 10(1):40-52. (In Russ.). doi:10.17816/OV10140-52
2. Zakharova M.A., Kuroyedov A.V. Domestic experience of generic drugs application in the treatment of glaucoma patients. Natsional'nyi zhurnal glaukoma. 2015; 14(4):78-87. (In Russ.).
3. Tatham A.J. The Use of Generic Medications for Glaucoma. J Ophthalmol. 2020:1-8. doi:10.1155/2020/1651265
4. Arici M.K., Arici D.S., Topalkara A., Güler C. Adverse effects of topical antiglaucoma drugs on the ocular surface. Clin Exper Ophthalmol. 2000; 28(2)113-117.
5. Noecker R.J., Herrygers L.A., Anwaruddin R. Corneal and conjunctival changes caused by commonly used glaucoma medications. Cornea. 2004; 23(5):490-496.
6. Hopes M., Broadway D. Preservative-free treatment in glaucoma is a sensible and realistic aim for the future. European Ophthalmic Review. 2010; 4(1):23-28. doi:10.17925/EOR.2010.04.01.23
7. Stalmans I., Sunaric Megevand G., Cordeiro M.F., Hommer A., Rossetti L., Goni F., Heijl A., Bron A. Preservative-free treatment in glaucoma: who, when, and why. Eur J Ophthalmol. 2013; 23(4):518-525. doi:10.5301/ejo.5000270
8. Erichev V.P., Ambartsumyan K.H., Fedorov A.A. Clinical and morphological evidence of the effect of preservatives on the eye surface in primary open-angle glaucoma. Natsional'nyi zhurnal glaukoma. 2014; 13(4):13-22. (In Russ.).
9. Thygesen J. Glaucoma therapy: preservative-free for all? Clin Ophthalmol. 2018; 12:707-717. doi:10.2147/opth.s150816
10. Asiedu K., Abu S.L. The impact of topical intraocular pressure lowering medications on the ocular surface of glaucoma patients: A review. J Curr Ophthalmol. 2019; 31(1):8-15. doi:10.1016/j.joco.2018.07.003
11. Erichev V.P., Averich V.V. Artificial “dry” eye syndrome induced by long-term ophthalmic hypotensive therapy. Possibilities of medical correction. Natsional'nyi zhurnal glaukoma. 2020; 19(1):55-60. (In Russ.). doi:10.25700/NJG.2020.01.08
12. Erichev V.P., Volzhanin A.V. Non-preservative glaucoma treatment. Natsional'nyi zhurnal glaukoma. 2020; 19(1):69-78. (In Russ.). doi:10.25700/NJG.2020.01.10
13. Hommer A., Thygesen J., Ferreras A., Wickstrom J., Friis M.M., Buchholz P., Walt J.G. A European perspective on costs and cost effectiveness of ophthalmic combinations in the treatment of open-angle glaucoma. Eur J Ophthalmol. 2008; 18(5):778-786.
14. Higginbotham E.J., Hansen J., Davis E.J., Walt J.G., Guckian A. Glaucoma medication persistence with a fixed combination versus multiple bottles. Curr Med Res Opin. 2009; 25(10):2543-2547. doi:10.1185/03007990903260129
15. Kuroyedov A.V. Medico-economic approaches in the treatment of glaucoma patients. Oftalmologičeskie vedomosti. 2010; 3(1): 51-62. (In Russ.).
16. Petrov S.Yu., Zinina V.S., Volzhanin A.V. The role of fixed dose combinations in the treatment of primary open-angle glaucoma. Vestnik oftal’mologii. 2018; 134(4):100-107. (In Russ.). doi:10.17116/oftalma2018134041100
17. Babushkin A.E., Orenburkina O.I., Matyukhina E.N. The efficacy of maximum hypotensive therapy with fixed dose combinations in primary open-angle glaucoma. RMJ Clinical Ophthalmology. 2016; 4:181-184. (In Russ.). doi:10.21689/2311-7729-2016-16-4-181-184
18. Kuroyedov A.V., Krinitsyna E.A., Sergeeva V.M., Gorodnichiy V.V. Changes in the structure of clinical and epidemiological characteristics of primary open-angle glaucoma over 10 years in patients coming to surgical treatment. RMJ Clinical Ophthalmology. 2017; 4:205-212. (In Russ.). doi:10.21689/2311-7729-2017-17-4-205-212
19. Kazanova S.Yu., Strakhov V.V., Yartsev A.V. Glaucoma treatment cost as seen by patients. Oftalmologičeskie vedomosti. 2013; 6(4):15-20. (In Russ.).
20. Glaukoma. Nacional'noe rukovodstvo [Glaucoma. National guideline]. Ed. E.A. Egorova. Moscow: GEOTAR-Media; 2013. 824 p. (In Russ.).
21. Nacional’noe rukovodstvo po glaukome dlya praktikuuyschikh vrachey [National glaucoma guideline for practitioners]. Eds E.A. Egorov, Ju.S. Astahov, V.P. Erichev. Moscow: GEOTAR-Media; 2015. 456 p. (In Russ.).
22. Nacional’noe rukovodstvo po glaukome dlya praktikuuyschikh vrachey [National glaucoma guideline for practitioners]. Eds E.A. Egorov, V.P. Erichev. Moscow: GEOTAR-Media; 2019. 384 p. (In Russ.).
23. Terminology and guidelines for glaucoma. 4th ed. European Glaucoma Society. Savona: PubliComm; 2014. 195 p. doi:10.1136/bjophthal-mol-2016-egsguideline.001
24. Petrov S.Yu., Lovpache D.N. The principles of modern medical treatment of glaucoma according to the 4th edition of the terminology and guidelines for glaucoma of the European Glaucoma Society. Russian Ophthalmological Journal. 2015; 2:88-98. (In Russ.).
25. Kuroyedov A.V., Nagornova Z.M., Tibieva Z.U., Krinitsyna E.A., Sergeeva V.M. Additive and combined glaucoma therapy: principles and practice. Russian Ophthalmological Journal. 2018; 11(2):71-81. (In Russ.). doi:10.21516/2072-0076-2018-11-2-71-81
26. Kuroyedov A.V., Brezhnev A.Yu., Lovpache J.N., Petrov S.Yu., Tibieva Z.U., Nagornova Z.M., Krinitsyna E.A., Sergeeva V.M. The feasibility of adopting «stepwise» initial approaches in treatment of patients with different stages of glaucoma. Natsional'nyi zhurnal glaukoma. 2018; 17(4):27-54. doi:10.25700/NJG.2018.04.03
27. Nagornova Z.M., Seleznev A.V., Kuroyedov A.V., Zavadsky P.Ch., Petrov S.Yu. Classification of approaches to primary open-angle glaucoma treatment considering real clinical practice. Natsional’nyi zhurnal glaukoma. 2019; 18(3):3-19. doi:10.25700/NJG.2019.03.01
28. Pfennigsdorf S., Eschstruth P., Hasemeyer S., Feuerhake C., Brief G., Grobeiu I., Shirlaw A. Preservative-free bimatoprost 0.03%/timolol 0.5% fixed combination in patients with glaucoma in clinical practice. Clin Ophthalmol. 2016; 10:1837-1846. doi:10.2147/OPTH.S106159
Review
For citations:
Kazanova S.Yu., Kazanov Yu.A. Digital technologies for the treatment of glaucoma. National Journal glaucoma. 2020;19(4):12-19. (In Russ.) https://doi.org/10.25700/NJG.2020.04.02
Views:
1148
Email this article 